Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 19 | Rogers Alfred Tate JrDirector, CEO & President | Derivative conversion | C | — 242 sh |
| Aug 7, 2026 traded Jul 14, 2026 |
| 19 | Lee Kam Yee SusannaDirector | Grant or award | A | — 42.6K sh | Aug 7, 2026 traded Jul 31, 2026 |
| 19 | Chan Kin KennethDirector | Grant or award | A | — 42.6K sh | Aug 7, 2026 traded Jul 31, 2026 |
| 19 | Allaire JeremyDirector, Chairman and CEO | Open-market sale · 10b5-1 plan | SELL | $342K 5,682 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 19 | Rogers Alfred Tate JrDirector, CEO & President | Derivative conversion | C | — 8 sh | Aug 7, 2026 traded Jul 14, 2026 |
| 18 | Buonasera DavidCHIEF TECHNOLOGY OFFICER | Open-market sale · 10b5-1 plan | SELL | $62K 2,602 sh | Aug 7, 2026 traded Aug 6, 2026 |
| 18 | Buonasera DavidCHIEF TECHNOLOGY OFFICER | Open-market sale · 10b5-1 plan | SELL | $95K 4,176 sh | Aug 7, 2026 traded Aug 6, 2026 |
| 18 | Thomson Matthew ChristopherHead of Revenue | Open-market sale · 10b5-1 plan | SELL | $30K 15.0K sh | Aug 7, 2026 traded Aug 5, 2026 |
| 17 | Newinski Laura MarieDirector | NABrookfield Private Equity Fund LP Grant or award | A | — 1,358 sh | Aug 7, 2026 traded Aug 7, 2026 |
| 17 | Quinton SashaEVP, Pres. CBG | Option exercise | M | — 7,549 sh | Aug 7, 2026 traded Aug 6, 2026 |
| 17 | Maher Michael WCFO & Treasurer | Option exercise · 10b5-1 plan | M | $318K 44.7K sh | Aug 7, 2026 traded Aug 7, 2026 |
| 17 | Saunders Brent LDirector, Chairman of the Board and CEO | Grant or award | A | — 281.9K sh | Aug 7, 2026 traded Aug 5, 2026 |
| 17 | Gosser TrishaCFO | Option exercise | M | — 29.6K sh | Aug 7, 2026 traded Aug 5, 2026 |
| 17 | Maher Michael WCFO & Treasurer | Option exercise · 10b5-1 plan | M | $318K 44.7K sh | Aug 7, 2026 traded Aug 7, 2026 |
| 17 | Kennedy PatrickDirector | Grant or award | A | — 1,605 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 17 | Ledbetter Samuel CraigSVP Chief Supply Chain Officer | Grant or award | A | — 2,404 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 16 | Gosser TrishaCFO | Tax withholding | F | $82K 9,465 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 16 | Alclear Investments, LLCDirector, 10% Owner, See Remarks | Open-market sale · 10b5-1 plan | SELL | $632K 9,803 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 16 | Alclear Investments, LLCDirector, 10% Owner, See Remarks | Open-market sale · 10b5-1 plan | SELL | $406K 6,006 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 16 | Xu ZhenyuChief Scientific Officer | Open-market sale · 10b5-1 plan | SELL | $75K 10.0K sh | Aug 7, 2026 traded Aug 7, 2026 |
| 16 | Alclear Investments, LLCDirector, 10% Owner, See Remarks | Open-market sale · 10b5-1 plan | SELL | $807K 12.1K sh | Aug 7, 2026 traded Aug 5, 2026 |
| 16 | Ditillo DavidChief Information Officer | Open-market sale · 10b5-1 plan | SELL | $422K 12.4K sh | Aug 7, 2026 traded Aug 6, 2026 |
| 15 | Viljoen NataschaDirector, President & CEO | Open-market sale · 10b5-1 plan | SELL | $807K 7,764 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 15 | Kelly-Gemmell Dorothy ElizabethDirector | Grant or award | A | — 6,333 sh | Aug 7, 2026 traded Aug 1, 2026 |
| 15 | Garis Douglas MichaelEVP&CFO | Tax withholding | F | $306K 11.7K sh | Aug 7, 2026 traded Aug 5, 2026 |
| 15 | Flammer Martina M.D.Chief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $2.37M 18.3K sh | Aug 7, 2026 traded Aug 6, 2026 |
| 15 | Kelly-Gemmell Dorothy ElizabethDirector | Grant or award | A | — 40.8K sh | Aug 7, 2026 traded Aug 1, 2026 |
| 15 | Buonasera DavidCHIEF TECHNOLOGY OFFICER | Open-market sale · 10b5-1 plan | SELL | $22K 871 sh | Aug 7, 2026 traded Aug 6, 2026 |
| 15 | Thong Hei Wa JacquelineDirector | Grant or award | A | — 10.1K sh | Aug 7, 2026 traded Jul 31, 2026 |
| 15 | Hoffman Christina MarieSr. VP & Chief Risk Officer | Option exercise | M | $259K 18.0K sh | Aug 7, 2026 traded Aug 6, 2026 |
| 15 | Fego Paul JSVP, Global Operations | Tax withholding | F | $375K 3,944 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 15 | Creviston Steven ESVP, Connectivity & Sensors | Tax withholding | F | $375K 3,949 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 15 | Hopmans JohnEVP, M&A and Strategic Finance | Tax withholding | F | $722K 3,970 sh | Aug 7, 2026 traded Aug 6, 2026 |
| 14 | Bruggeworth Robert ADirector, President and CEO | Tax withholding | F | $1.56M 16.4K sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Bailey A Robert DEVP & Chief Legal Officer | Grant or award | A | — 33.6K sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Allaire JeremyDirector, Chairman and CEO | Open-market sale · 10b5-1 plan | SELL | $16K 262 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Bonnefoy LucPresident, Surgical | Grant or award | A | — 16.8K sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Gallagher CindyCAO | Option exercise | M | — 9,070 sh | Aug 7, 2026 traded Aug 6, 2026 |
| 13 | Hashad YehiaEVP of R&D and CMO | Grant or award | A | — 21.0K sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Allaire JeremyDirector, Chairman and CEO | Open-market sale · 10b5-1 plan | SELL | $9,262 154 sh | Aug 7, 2026 traded Aug 5, 2026 |